Zoledronic acid maintains BMD gains after overlapping teriparatide, denosumab treatment
Posted on: 22 September, 2020
A single dose of zoledronic acid effectively maintains large and rapid gains in spine and hip bone mineral density after 15 months of overlapping teriparatide and denosumab therapy, according to a speaker.
